{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2019,"dc_identifier":"nl.oorg10123.2j.2019.717","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/guidelines-on-benefit-risk-assessment-of-presence-of-phthalates-in-certain-medical","dc_title":"Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties. | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2019-12-16","foi_retrievedDate":"2024-11-30","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2019.717"}